Skip to main content

Table 5 Treatment approach in pregnancy and association with practice setting

From: The use of intravenous iron in pregnancy: for whom and when? A survey of Australian and New Zealand obstetricians

  Frequency (n)a and percentage (%) Practice setting (n) and percentage (%)b,c p-value
Public Not public
Oral iron always first-line, IV possibly second-line
 IDAP Yes 141 (33.9) 112 (79.4) 29 (20.6) 0.705C
No 275 (66.1) 214 (77.8) 61 (22.2)
 ID without anaemia Yes 188 (45.9) 148 (78.7) 40 (21.3) 0.846C
No 222 (54.1) 173 (77.9) 49 (22.1)  
Oral usually first-line, IV sometimes first-line and always second-line
 IDAP Yes 247 (59.4) 192 (77.7) 55 (22.3) 0.705C
No 169 (40.6) 134 (79.3) 35 (20.7)  
 ID without anaemia Yes 91 (22.2) 65 (71.4) 26 (28.5) 0.072C
No 319 (77.8) 256 (80.3) 63 (19.7)  
IV usually first-line
 IDAP Yes 3 (0.7) 3 (100) 0 (0) 1.000F
No 413 (99.3) 323 (78.2) 90 (21.8)  
 ID without anaemia Yes 2 (0.5) 2 (100) 0 (0) 1.000F
No 408 (99.5) 319 (78.2) 89 (21.8)  
IV never
 IDAP Yes 1 (0.2) 1 (100)) 0 (0) 1.000F
No 415 (99.8) 325 (78.3) 90 (21.7)  
 ID without anaemia Yes 68 (16.6) 55 (80.9) 13 (19.1) 0.571C
No 342 (83.4) 266 (77.8) 76 (22.2)  
No consistent policy
 IDAP Yes 19 (4.6) 14 (73.7) 5 (26.3) 0.575C
No 397 (95.4) 312 (78.6) 85 (21.4)  
 ID without anaemia Yes 47 (11.5) 38 (80.9) 9 (19.1) 0.651C
No 363 (88.5) 283 (78.0) 80 (22.0)  
  1. Abbreviations: IV intravenous; IDAP iron deficiency anaemia in pregnancy; ID iron deficiency. Superscript: F, Fisher’s Exact; C, Pearson’s Chi-Squared
  2. aFor IDAP n = 416; For ID without anaemia n = 413
  3. bFor practice setting analysis IDAP n = 416, ID without anaemia n = 410
  4. c“Public” represents clinicians whose practice sites include metropolitan public and/or non-metropolitan public hospitals; “not public” includes clinicians who practice exclusively in metropolitan private hospitals, non-metropolitan private hospitals or others